Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Long Fund Gp Llc Viking currently holds 22,819,798 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Long Fund Gp Llc Viking has been a net buyer of EDIT stock. They have purchased $177.3K and sold $0 worth of shares.
Long Fund Gp Llc Viking's most recent insider trade was on Jun 11, 2019, when they purchased 7,189 shares at $8.58 per share.
Long Fund Gp Llc Viking serves as Executive at Editas Medicine, Inc. (EDIT). They have executed 12 insider transactions totaling $177.3K over their tenure at the company.
Long Fund Gp Llc Viking holds the position of Executive at Editas Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Long Fund Gp Llc Viking has shown a buying trading pattern, with $177.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Long Fund Gp Llc Viking was on Jun 10, 2019, when they purchased $62.6K worth of UROV shares. This transaction involved 7,500 shares at $8.35 per share.
Long Fund Gp Llc Viking currently owns 22,819,798 shares of Editas Medicine, Inc. (EDIT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Long Fund Gp Llc Viking's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Long Fund Gp Llc Viking has 12 Form 4 filings on record as an insider at Editas Medicine, Inc..
Set alerts for Long Fund Gp Llc Viking and 40,000+ other insiders.